$0.8524
-0.0201-2.3%
Last update: Oct 23, 4:35 PM
Phio Pharmaceuticals Corp
PHIONASDAQ
Phio Pharmaceuticals (PHIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.36 | $-0.23 | $-0.42 | $-0.44 |
| Actual | $-0.36 | $-0.34 | $-0.15 | $-0.44 |
| Surprise | 0.00% | -47.8% | +64.3% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.36 | $-0.39 | $-0.13 | $-0.09 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.36 | $-0.36 | 0.00 % |
| Q1 | May 7, 2026 | $-0.34 | $-0.23 | -47.8 % |
| Q4 | Mar 5, 2026 | $-0.15 | $-0.42 | 64.3 % |
| Q3 | Nov 13, 2025 | $-0.44 | $-0.44 | 0.00 % |
